Cargando…
Esophagitis and SARS-CoV-2 vaccine
Autores principales: | Sriwijitalai, Won, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899001/ https://www.ncbi.nlm.nih.gov/pubmed/36777492 http://dx.doi.org/10.1016/j.medcle.2022.07.023 |
Ejemplares similares
-
Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023) -
Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022) -
Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022) -
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence
por: Mungmunpuntipanjtip, Rujittika, et al.
Publicado: (2022) -
Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)